Relative risk of upper gastrointestinal complications among users of acetaminophen and nonsteroidal anti-inflammatory drugs

Epidemiology

Volumn 12, Issue 5, 2001, Pages 570-576

  García Rodríguez, Luis Alberto ^a   Hernández Díaz, Sonia ^b  

^a Department of Pharmacoepidemiology   (Spain)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Acetaminophen; Gastrointestinal hemorrhage; Gastrointestinal toxicity; Nitrates; Nonsteroidal anti inflammatory drugs; Peptic ulcer

Indexed keywords

ACECLOFENAC; ACEMETACIN; AZAPROPAZONE; CIMETIDINE; DICLOFENAC; ETODOLAC; FAMOTIDINE; FENBUFEN; FENOPROFEN; FLURBIPROFEN; GLYCERYL TRINITRATE; HISTAMINE H2 RECEPTOR ANTAGONIST; IBUPROFEN; INDOMETACIN; ISOSORBIDE DINITRATE; ISOSORBIDE MONONITRATE; KETOPROFEN; MEFENAMIC ACID; MELOXICAM; MISOPROSTOL; NABUMETONE; NAPROXEN; NITRIC ACID DERIVATIVE; NIZATIDINE; NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE; PARACETAMOL; RANITIDINE; TIAPROFENIC ACID; UNINDEXED DRUG;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; DIGESTIVE SYSTEM HEMORRHAGE; DIGESTIVE SYSTEM PERFORATION; DOSE RESPONSE; DRUG HALF LIFE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OSTEOARTHROPATHY; PAIN; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SLOW RELEASE FORMULATION; UNITED KINGDOM;

ACETAMINOPHEN; ADULT; AGED; ANALGESICS, NON-NARCOTIC; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CASE-CONTROL STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GASTROINTESTINAL HEMORRHAGE; GREAT BRITAIN; HALF-LIFE; HUMANS; INCIDENCE; LOGISTIC MODELS; MALE; MIDDLE AGED; PEPTIC ULCER; POPULATION SURVEILLANCE; RISK;

EID: 0034892763     PISSN: 10443983     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001648-200109000-00018     Document Type: Article

References (34)

1. Non-steroidal anti-inflammatory drugs and peptic ulcers: Facts and figures multiply, but do they add up?
2. Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs: A meta-analysis
3. The impact of research quality and study design on epidemiologic estimates of the effect of NSAIDs on upper gastrointestinal pathology
4. Variability in risk of gastrointestinal complications with individual NSAIDs: Results of a collaborative meta-analysis
5. Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs
6. Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs
7. A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs
8. Misoprostol reduces serious gastrointestinal complication in patients with rheumatoid arthritis receiving non-steroidal anti-inflammatory drugs
9. Nitrovasodilators, low-dose aspirin, other nonsteroidal antiinflammatory drugs, and the risk of upper gastrointestinal bleeding
10. Risk of upper gastrointestinal bleeding and perforation associated with individual nonsteroidal anti-inflammatory drugs
11. Validation of information recorded on general practitioner based computerised data resource in the United Kingdom
12. Use of the UK General Practice Research Database for pharmacoepidemiology
13. Case-control studies: Sampling the source population
14. Individual non-steroidal anti-inflammatory drugs and hospitalizations for upper gastrointestinal bleeding and perforation
15. Upper gastrointestinal bleeding in relation to previous use of analgesics and non-steroidal anti-inflammatory drugs
16. Relation of upper gastrointestinal bleeding to non-steroidal anti-inflammatory drugs and aspirin: A case-control study
17. Non-steroidal anti-inflammatory drugs and upper gastrointestinal bleeding: A postmarketing surveillance case-control study
18. Variation in the risk of peptic ulcer complications with nonsteroidal antiinflammatory drug therapy
19. Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs
20. Dose response curves with time dependent exposure: The case of acetaminophen gastrointestinal side effects
21. Cyclooxygenase-1 and cyclooxygenase-2 selectivity of widely used nonsteroidal anti-inflammatory drugs
22. Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: A full in vitro analysis
23. Risk of aspirin-associated major upper-gastrointestinal bleeding with enteric-coated or buffered product
24. Gastrointestinal toxicity of over-the-counter analgesics
25. Variability in the risk of major gastrointestinal complications from nonaspirin nonsteroidal anti-inflammatory drugs
26. COX-2 inhibitors
27. Safety experience with nabumetone versus diclofenac, naproxen, ibuprofen, and piroxicam in osteoarthritis and rheumatoid arthritis
28. An updated safety profile of etodolac in several thousand patients
29. Gastrointestinal tolerability of meloxicam compared to diclofenac in osteoarthritis patients
30. Basic methods for sensitivity analysis of biases
31. The impact of differential recall on the results of case-control studies
32. Using prescription claims for drugs available over-the-counter (OTC)